Karhleight

Drospirenone/Ethinylestradiol, the active ingredient in Karhleight, is a combined estrogen‑progestogen oral contraceptive presented as a tablet for oral use. It prevents pregnancy and can help regulate menstrual cycles.

GNH USA supplies Karhleight as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Karhleight, a combined estrogen‑progestogen oral contraceptive, is used in hormonal regulation of the reproductive system.

- Prevention of pregnancy: provides reliable contraceptive protection by inhibiting ovulation. - Regulation of menstrual cycles: helps achieve more predictable bleeding patterns. - Management of menstrual‑related symptoms: may reduce dysmenorrhea and premenstrual discomfort.

Karhleight may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional mild to moderate pain. - Spotting: irregular bleeding between periods. - Weight gain: slight increase in body weight. - Mood changes: fluctuations in emotional state.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins. - Arterial thrombosis: clot formation in arteries leading to stroke or heart attack. - Severe hypertension: sudden high blood pressure. - Liver disorders: jaundice or hepatic dysfunction. - Gallbladder disease: inflammation or stones. - Anaphylaxis: rare severe allergic reaction.

Before prescribing Karhleight, clinicians should evaluate individual risk factors and contraindications.

- Cardiovascular risk assessment: review history of clotting disorders, hypertension, or smoking. - Liver function review: ensure normal hepatic function before initiation. - Smoking status: avoid use in women over 35 who smoke. - Medication review: consider interactions with enzyme‑inducing drugs. - Pregnancy testing: confirm non‑pregnant status prior to start. - Store at room temperature: keep below 25 °C in the original pack, protect from moisture.

Karhleight can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., phenytoin, carbamazepine): may reduce contraceptive effectiveness. - Rifampin or St. John's wort: strong inducers that can lower hormone levels.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., macrolides): may modestly affect hormone metabolism. - Antifungal agents (e.g., ketoconazole): can increase hormone concentrations. - Diuretics and antihypertensives: may enhance drospirenone’s anti‑mineralocorticoid effect, affecting blood pressure.